Physician profile
Ralph E Delius
NPI 1033189915
$1,252.41
in general payments reported to CMS, 2019-2025
12 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Phlebology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.83 · 2020: $26.71 · 2021: $290 · 2022: $239 · 2023: $250 · 2024: $285 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $430.62 | 2021-2024 | Puraply |
| Medtronic, INC. | $341.28 | 2021-2025 | Venaseal |
| Boston Scientific Corporation | $252.92 | 2021-2025 | Varithena Administration Pack |
| Convatec INC. | $57.68 | 2024 | |
| Tactile Systems Technology INC | $49.96 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Integra Lifesciences Corporation | $25.84 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Philips North America LLC | $20.83 | 2019 | |
| Solventum Corporation | $15.87 | 2024 | 3m Cavilon, V.A.C. Granufoam, Promogran Prisma |
| Medtronic Vascular, INC. | $15.41 | 2020 | |
| Hydrofera LLC | $15.12 | 2023 | Hydrofera Blue |
| Urgo Medical North America, LLC | $14.40 | 2025 | Urgok2 |
| Kci USA, INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Delius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.